Leukemans suspended for two years

Björn Leukemans

Björn Leukemans (Image credit: Brecht Decaluwé)

The disciplinary commission of the Vlaamse Gemeeenschap (Flemish Community) has given Björn Leukemans a two year suspension for using testosterone, beginning February 14. The former Team Predictor-Lotto (now Silence-Lotto) rider indicated that he would appeal the ban.

Leukemans, 30, tested positive in an unannounced out-of-competition test shortly before the World Championships. He claimed that the positive test was due to a medication prescribed by a team doctor The team fired both Leukemans and the doctor.

The Commission was not persuaded by arguments that he relied on the doctor's advice and was therefore innocent. "Even if the product is prescribed by a doctor, the rider still remains responsible for what he is administered," it ruled.

The rider did not give a comment on the ban, but his lawyer, Kristof de Saedeleer, told Sporza.be, "He is totally disillusioned. He has lost all faith in other people. However, there is no doubt that we will file an appeal. We find the sanction out of proportion."

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura's specialises in covering doping, anti-doping, UCI governance and performing data analysis.